|
Contents
|
|
|
|
|
|
|
Astrocytomas |
|
|
|
|
Christensen K, Schrøder HD and Kristensen BW
CD133 identifies perivascular niches in grade II–IV astrocytomas
J Neurooncol.
July 09, 2008. [Epub ahead of print]
.JPG) Abstract
|
|
|
Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn
HM, Held-Feindt J.
Expression of stem cell markers in human astrocytomas of different WHO
grades
J Neurooncol.
2008 Jan;86(1):31-45.
Epub 2007 Jul 5
Abstract
| .png)
Reprint
|
|
|
Mao Y, Zhou L, Zhu W, Wang X, Yang G, Xie L, Mao
X, Jin K.
Proliferative status of tumor stem cells may be correlated with
malignancy grade of human astrocytomas
Front
Biosci. 2007 Jan 1;12:2252-9
Abstract
|
|
|
Mao
XG, Zhang X, Xue XY, Guo G, Wang P, Zhang W, Fei Z, Zhen HN, You SW, Yang H
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15
Transl Oncol. 2009
December 1; 2(4):
247–257
Abstract | .png)
Full text |
Reprint
|
|
|
Wan
F, Herold-Mende C, Campos B, Centner FS, Dictus C, Becker N, Devens F,
Mogler C, Felsberg J, Grabe N, Reifenberger G, Lichter P, Unterberg A,
Bermejo JL, Ahmadi R.
Association of stem cell-related markers and survival in astrocytic gliomas.
Biomarkers. 2011 Mar;16(2):136-43.
Abstract |
.gif) Related articles
|
|
|
Brain
Tumors |
|
|
|
|
Cheng
JX, Liu CNO, Zhang X
How powerful is CD133 as a cancer stem cell marker in brain tumors?
Cancer Treat Rev. 2009 Apr 14; [Epub ahead of print]
Abstract
|
|
|
Cancer
Research |
|
|
|
|
Brown MD, Gilmore PE, Hart CA, Samuel JD, Ramani VA, George NJ, Clarke NW
Characterization of benign and malignant prostate epithelial Hoechst 33342
side populations
Prostate. 2007 Sep 15;67(13):1384-96.
Published Online: 18 Jul 2007
Abstract
|
|
|
Immervoll H, Hoem D, Sakariassen PO, Steffensen
OJ, Molven A
Expression of the "stem cell marker" CD133 in pancreas and
pancreatic ductal adenocarcinomas
BMC Cancer 2008, 8:48 (8 February 2008)
Abstract |
Reprint
|
|
|
Richardson GD, Robson CN, Lang SH, Neal DE,
Maitland NJ, Collins AT
CD133, a novel marker for human prostatic epithelial stem cells
J Cell Sci.
2004 Jul 15;117(Pt 16):3539-45.
Epub 2004 Jun 29
Abstract |
Full text |
Reprint
|
|
|
Glioblastoma |
|
|
|
|
Cheng
L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN, Bao S.
Elevated invasive potential of glioblastoma stem cells.
Biochem Biophys Res Commun. 2011 Mar 1;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Liu
Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, Tso JL, Liu JY, Konkankit
V, Cloughesy TF, Mischel PS, Lane TF, Liau LM, Nelson SF, Tso CL
Molecular
properties of CD133+ glioblastoma stem cells derived from
treatment-refractory recurrent brain tumors
J Neurooncol.
2009 May 26. [Epub ahead of print]
Abstract |
Full text |
Reprint
|
|
|
Loja
T, Chlapek P, Kuglik P, Pesakova M, Oltova A, Cejpek P, Veselska R
Characterization of a GM7 glioblastoma cell line showing CD133 positivity
and both cytoplasmic and nuclear localization of nestin
Oncol Rep. 2009 Jan;21(1):119-27
Abstract
|
|
|
Pallini
R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F,
Martini M, De Maria R, Larocca LM
Expression
of the stem cell marker CD133 in recurrent glioblastoma and its value for
prognosis
Cancer. 2010 Aug
30. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Shervington A, Lu C
Expression of multidrug resistance genes in normal and cancer stem cells
Cancer Invest. 2008 Jun;26(5):535-42
Abstract
|
|
|
Son
MJ, Woolard K, Nam DH, Lee J, Fine HA
SSEA-1 is an enrichment marker for tumor-initiating cells in human
glioblastoma
Cell Stem Cell. 2009 May 8;4(5):440-52
Abstract
|
|
|
Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E,
Kohsaka S, Tanino M, Nishihara H, Tanaka S.
Promoter hypomethylation regulates CD133 expression in human gliomas
Cell Res. 2008 Aug 5; [Epub ahead of print]
Abstract
|
|
|
Tchoghandjian A, Baeza N, Colin C, Cayre M,
Metellus P, Beclin C, Ouafik L, Figarella-Branger D.
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Brain Pathol. 2009 Feb 20;. [Epub ahead of print]
Abstract |
Full text |
Reprint
|
|
|
Wang HM, Yang XJ, Dong XT, Li Y, Wang W, Ming HL, Zhang B, Yu SP.
Correlation
between the distribution of CD133-positive cells and the proliferation of
microvessels in glioblastoma multiforme.
Zhonghua Yi Xue Za Zhi.
2011 Mar 22;91(11):781-5.
Abstract |
Related articles
|
|
Niches
|
|
|
|
Christensen K, Schrøder HD, Kristensen BW.
CD133(+) niches and single cells in glioblastoma have different phenotypes.
J Neurooncol. 2010 Dec 24;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Gliomas |
|
|
|
|
Bleau AM, Howard BM, Taylor LA, Gursel D,
Greenfield JP, Lim Tung HY, Holland EC, Boockvar JA.
New strategy for the analysis of phenotypic marker antigens in brain
tumor-derived neurospheres in mice and humans
Neurosurg Focus. 2008 Mar;24(3-4):E28
Abstract |
Full text |
Reprint
|
|
|
Clément
V, Dutoit V, Marino D, Dietrich PY, Radovanovic I
Limits
of CD133 as a marker of glioma self-renewing cells
Int
J Cancer. 2009 Jul 1;125(1):244-8. Epub 2009 Feb 10
Abstract
|
|
|
Dell'Albani P
Stem
cell markers in gliomas
Neurochem Res. 2008
Dec;33(12):2407-15. Epub 2008 May 21
Abstract |
Full text |
Reprint
|
|
|
Field
M, Alvarez A, Bushnev S, Sugaya K.
Embryonic stem cell markers distinguishing cancer stem cells from normal
human neuronal stem cell populations in malignant glioma patients.
Clin Neurosurg. 2010;57:151-9.
Abstract |
Reprint |
Related articles
|
|
|
Garcia
JL, Perez-Caro M, Gomez-Moreta JA, Gonzalez F, Ortiz J, Blanco O, Sancho M,
Hernandez-Rivas JM, Gonzalez-Sarmiento R, Sanchez-Martin M
Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive
and angiogenic profile but different proliferative signatures among high
grade gliomas
BMC Cancer. 2010 Aug 24;10(1):454. [Epub ahead of print]
Abstract |
Full text |
Reprint
|
|
|
Griguer CE, Oliva CR, Gobin E, Marcorelles P,
Benos DJ, Lancaster JR Jr, Gillespie GY
CD133 is a marker of bioenergetic stress in human glioma
PLoS ONE. 2008;3(11):e3655. Published online
2008 November 5
Abstract |
Full text |
Reprint
|
|
|
Rebetz J, Tian D, Persson A, Widegren B, Salford
LG, Englund E, Gisselsson D, Fan X
Glial progenitor-like phenotype in low-grade glioma and enhanced
CD133-expression and neuronal lineage differentiation potential in
high-grade glioma
PLoS ONE. 2008 Apr 9;3(4):e1936
Abstract |
Full text |
Reprint
|
|
|
Strojnik T, Røsland GV, Sakariassen PO, Kavalar
R, Lah T.
Neural stem cell markers, nestin and musashi proteins, in the progression
of human glioma: correlation of nestin with prognosis of patient survival
Surg Neurol.
2007 Aug;68(2):133-43.
Epub 2007 May 30
Abstract
|
|
|
Yao
Y, Wang X, Jin K, Zhu J, Wang Y, Xiong S, Mao Y, Zhou L
B7-H4 is preferentially expressed in non-dividing brain tumor cells and
in a subset of brain tumor stem-like cells
J Neurooncol.
2008 May 14. [Epub ahead of print]
Abstract
|
|
|
Zeppernick F, Ahmadi R, Campos B, Dictus C,
Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Clin Cancer Res. 2008 Jan 1;14(1):123-9
Abstract
|
|
|
Zhang
M, Song T, Yang L, Chen R, Wu L, Yang Z, Fang J
Nestin
and CD133: valuable stem cell-specific markers for determining clinical
outcome of glioma patients
J Exp Clin Cancer Res. 2008 Dec
24;27:85
Abstract |
Full text |
Reprint
|
|
|
Medulloblastoma |
|
|
|
|
Ward
RJ, Lee L, Graham K, Satkunendran T, Yoshikawa K, Ling E, Harper L, Austin
R, Nieuwenhuis E, Clarke ID, Hui CC, Dirks PB
Multipotent
CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma
Cancer Res. 2009
Jun 1;69(11):4682-90
Abstract
|
|
|
Oligodendroglial
Tumors |
|
|
|
|
Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A,
Bogdahn U, Beier CP
CD133
expression and cancer stem cells predict prognosis in high-grade
oligodendroglial tumors
Brain
Pathol. 2008 Jul;18(3):370-7. Epub 2008 Mar 27
Abstract |
Full text |
Reprint
|
|
|
Häyry V, Tynninen O, Haapasalo HK, Wölfer J,
Paulus W, Hasselblatt M, Sariola H, Paetau A, Sarna S, Niemelä M,
Wartiovaara K, Nupponen NN.
Stem cell protein BMI-1 is an independent marker for poor prognosis in
oligodendroglial tumours
Neuropathol
Appl Neurobiol. 2008 Mar 10; [Epub ahead of print]
Abstract
|
|
|
Neuroblastoma |
|
|
|
|
Tong QS, Zheng LD, Tang ST, Ruan QL, Liu Y, Li SW, Jiang GS, Cai JB
Expression and clinical significance of stem cell marker CD133 in human
neuroblastoma
World J Pediatr. 2008 Feb;4(1):58-62
Abstract
|
|
